Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
115 participants
OBSERVATIONAL
2010-11-30
2021-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study of Biomarkers of Mild Traumatic BRAIN Injury
NCT04032509
S100 Biomarker in the Acute Management of Mild Head Injuries
NCT02650765
Biochemical Diagnostics of Mild Traumatic Brain Injury (TBI) and Concussion in Children and Adolescents
NCT04288167
Pathology in the Brain After mTBI - A Multimodal MRI Study
NCT01936792
Mild Traumatic Brain Injury Registry
NCT01688869
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. To improve clinical assessment of mTBI in the acute phase
2. To assemble better knowledge of diffusion tensor imaging as a diagnostic tool in mTBI
3. To improve neuropsychological evaluation of mTBI Main focus on psychosocial functioning / outcome / correlates E.g. Resilience, PTSD
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Inhabitant of Pirkanmaa hospital district
* Age between 18 and 60 years
Exclusion Criteria
* Drug addiction
* Chronic neurological disease
* Earlier brain injury
* Diagnosed psychiatric disease
* Hearing or sight deficiency
* Native language other than finnish
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tampere University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Teemu Luoto
Medical Researcher
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Teemu M. Luoto, M.D.
Role: PRINCIPAL_INVESTIGATOR
Tampere University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tampere University Hospital
Tampere, , Finland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R10027
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.